Abstract:Inflammatory bowel diseases (IBD) are a group of chronic inflammatory conditions of the gastrointestinal tract associated with multiple pathogenic factors, including dysregulation of the immune response. Effector CD4 + T cells and regulatory CD4 + T cells (Treg) are central players in maintaining the balance between tolerance and inflammation. Interestingly, genetic modifications in these cells have been implicated in regulating the commitment of specific phenotypes and immune functions. However, the transcriptional program controlling the pathogenic behavior of T helper cells in IBD progression is still unknown. In this study, we aimed to find master transcription regulators controlling the pathogenic behavior of effector CD4 + T cells upon gut inflammation. To achieve this goal, we used an animal model of IBD induced by the transfer of naïve CD4 + T cells into recombination-activating gene 1 ( Rag1 ) deficient mice, which are devoid of lymphocytes. As a control, a group of Rag1 −/− mice received the transfer of the whole CD4 + T cells population, which includes both effector T cells and Treg. When gut inflammation progressed, we isolated CD4 + T cells from the colonic lamina propria and spleen tissue, and performed bulk RNA-seq. We identified differentially up- and down-regulated genes by comparing samples from both experimental groups. We found 532 differentially expressed genes (DEGs) in the colon and 30 DEGs in the spleen, mostly related to Th1 response, leukocyte migration, and response to cytokines in lamina propria T-cells. We integrated these data into Gene Regulatory Networks to identify Master Regulators, identifying four up-regulated master gene regulators (Lef1, Dnmt1, Mybl2, and Jup ) and only one down-regulated master regulator ( Foxo3 ). The altered expression of master regulators observed in the transcriptomic analysis was confirmed by qRT-PCR analysis and found an up-regulation of Lef1 and Mybl2 , but without differences on Dnmt1, Jup, and Foxo3 . These two master regulators have been involved in T cells function and cell cycle progression, respectively. We identified two master regulator genes associated with the pathogenic behavior of effector CD4 + T cells in an animal model of IBD. These findings provide two new potential molecular targets for treating IBD.

Wnt–β-catenin activation epigenetically reprograms Treg cells in inflammatory bowel disease and dysplastic progression

Wnt/β-catenin activation epigenetically reprograms Regulatory T cells in IBD and progression to dysplasia.

Dysregulation of Wnt/β-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells

TGF-|[bgr]|1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4|[plus]|Foxp3|[plus]| regulatory T cells

Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer

Dysregulated Lysine Acetyltransferase 2b Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10

Identification of master regulator genes controlling pathogenic CD4+ T cell fate in inflammatory bowel disease through transcriptional network analysis

WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers

Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma.

Deletion of TNF in Winnie- APCMin/+ Mice Reveals Its Dual Role in the Onset and Progression of Colitis-Associated Colorectal Cancer

The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer

Transcriptional modulation of pattern recognition receptors in acute colitis in mice

The canonical Hippo pathway components modulate the differentiation of lamina propria regulatory T cells and T helper 17-like regulatory T cells in mouse colitis

An epigenetic basis for sustained inflammatory epithelial progenitor cell states in Crohn's disease

Multiplex spatial omics reveals changes in immune-epithelial crosstalk during inflammation and dysplasia development in chronic IBD patients

Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

The FOXP3 + Pro-inflammatory T cell: A Potential Therapeutic Target in Crohn's Disease

Epithelial Ezh2 Serves As An Epigenetic Determinant In Experimental Colitis By Inhibiting Tnf Alpha-Mediated Inflammation And Apoptosis

The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population

Expression of RORγt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer

IL-17+ Regulatory T Cells in the Microenvironments of Chronic Inflammation and Cancer